UChicago Medicine and the attorney for health care wins NIH grant to find new ways to prevent type 1 diabetes -
The University of Chicago Medicine and Hospital attorney / health care attorney for the children received a five-year, $ 1.8 million grant from the national Institutes of health to find new ways to delay and prevent diabetes type 1. the grant will establish the first type 1 diabetes TrialNet Clinical Center in Chicago.
TrialNet, long-term, international collaboration managed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the NIH, is working to identify people at risk or in the early stages of type 1 diabetes -. mainly by the inclusion of family members of people who have diabetes
once identified, the researchers offer individuals the opportunity to participate in studies that introduce prevention and treatment tactics that experts believe may have an impact on disease progression. Because early diagnosis of type 1 diabetes is the key to successful treatment, previous TrialNet studies have shown the effectiveness of this early intervention. The results show people at risk for type 1 diabetes who participated in TrialNet "the way Prevention Study" were more likely to be diagnosed early, which in turn leads to better outcomes for patients
"Having a TrialNet center in the Chicago area is a great opportunity for families of people with type 1 diabetes in our community," said Louis Philipson, MD, PhD, professor of medicine and pediatrics and Director University of Chicago Medicine Kovler Diabetes Center. "We are very pleased to work with our lawyer friends to reach the largest number of patients and families as possible."
By participating in TrialNet center, patients in the Chicago area will have access to advanced studies designed to prevent and treat type 1 diabetes TrialNet Chicago Center contribute to the overall screening of 15,000 to 20,000 people each year TrialNet network to achieve the research objectives.
"in people with type 1 diabetes, the importance of early diagnosis can not be overstated, "said NIDDK Director Griffin P. Rodgers, MD. "Early diagnosis means that people are less likely to develop diabetic ketoacidosis, early diagnosis of life-threatening conditions prognosis. Means as people can often control their diabetes more quickly, which can slow the loss of insulin-producing cells and can delay complications. "
downtown Chicago will join a network of 18 clinical centers TrialNet working in cooperation with over 0 locations across the US, Canada, Finland, Great Britain, Italy, Germany, Australia and New Zealand.
"We are excited to partner with the University of Chicago for a TrialNet center," said Kanika Ghai, MD, director of the Division of Endocrinology at the Hospital of the Children's Lawyer . "This is an extraordinary opportunity to better serve children and adults in our community who are at risk for diabetes type 1. This will allow us to offer studies that evaluate new approaches to the treatment and prevention of diabetes Type 1. "
EmoticonEmoticon